Introduction {#s1}
============

Alzheimer's disease (AD) begins with a long asymptomatic period when only its neuropathogenesis progresses (Price and Morris, [@B46]; Yaffe et al., [@B63]; Jack et al., [@B27]). It has been emphasized that the early detection of AD through biomarkers will help target early intervention, leading to the potential delay of AD onset (Sperling et al., [@B56]; Soldan et al., [@B55]). The hallmark characteristics of AD at the present time include aberrant reduced β-amyloid protein (Aβ) in cerebrospinal fluid (CSF; Visser et al., [@B61]), increased amyloid and Tau tracer retention revealed by positron emission tomography (PET; Tosun et al., [@B59]), and hippocampus atrophy as detected by magnetic resonance imaging (MRI; Hampel et al., [@B20]). However, the clinical applicability of these biomarkers is limited due to either invasive or expensive. Therefore, there is an urgent need to establish a noninvasive and less expensive AD biomarker to identify high-risk individuals and initiate interventions at an early stage (Bateman et al., [@B3]).

The retina and optic nerve extend from the diencephalon during embryonic development and are thus considered as part of the central nervous system, which can be directly visualized (London et al., [@B38]). The retinal nerve fiber layer (RNFL) is composed primarily of ganglion cell axons before they coalesce in the optic nerve. Early postmortem studies by Hinton et al. ([@B22]) demonstrated the axonal degeneration of the optic nerve and decreased thickness of the RNFL in AD patients. Since then, noninvasive optical imaging techniques have increasingly been used to study the ocular disorders and the ocular involvement in neurological diseases (Kirbas et al., [@B30]; Saidha et al., [@B50]; Bussel et al., [@B8]; Doustar et al., [@B16]). In particular, optical coherence tomography (OCT), a rapid and high-resolution imaging tool, enables precise and accurate measurement of *in vivo* RNFL thickness (Huang et al., [@B23]).

Evidences have suggested that patients with AD or mild cognitive impairment (MCI) demonstrated thinner RNFL as compared with heathy age-matched controls (He et al., [@B21]; Thomson et al., [@B58]; den Haan et al., [@B15]), indicating that RNFL thinning is an early event in AD pathology. RNFL thickness has been proved to associate with global cognitive status (Ascaso et al., [@B2]; Oktem et al., [@B45]) or episodic memory in MCI patients (Shen et al., [@B51]), as well as the progressive changes of cognition (Trebbastoni et al., [@B60]). Recently, two population-based cohort studies further reported that thinner RNFL was associated with current and future cognitive impairment, and could predict the incidence of dementia within 4.5 years in nondemented participants (Ko et al., [@B32]; Mutlu et al., [@B42]). These findings suggested that retinal and brain neurodegeneration may occur in parallel to some extent, and RNFL thickness could serve as a noninvasive and less expensive biomarker of AD.

Given the wide variance of RNFL thickness in old adults, OCT measurement at a single time point may not be informative enough to the identification of abnormal RNFL profiles in AD patients (Mok et al., [@B41]). In our previous studies, we found that longitudinal reduction of RNFL thickness was associated with the decline of episodic memory in old adults (Shen et al., [@B52]), and those who suffered cognitive decline within 25 months had more reduction of RNFL thickness with respect to old adults with stable cognition (Shi et al., [@B53], [@B54]). It supports the hypothesis that a longitudinal change of RNFL thickness would be more indicative of cognitive deterioration among the elderly population.

However, whether the longitudinal changes of RNFL thickness associated with the classical AD biomarkers, such as atrophy of hippocampus, remains largely unknown at the present time. This gap of knowledge makes it difficult to ascertain whether the changes in RNFL thickness could reflect the pathologies of central nervous system. Therefore, we conducted a 12-month prospective cohort investigation as a pilot study to establish a system to validate the longitudinal association between RNFL thinning and specific brain atrophy in nondemented old adults. Our primary hypothesis was that RNFL attenuation was associated with hippocampus atrophy in older adults with normal cognition.

Materials and Methods {#s2}
=====================

Study Population {#s2-1}
----------------

This study protocol was approved by the Human Research Ethics Committee of the Tenth People's Hospital in Shanghai, China (RES-2013015). Participants were recruited from the "Cognitive Training Program" *via* a flyer distribution (Cheng et al., [@B10]). All participants signed the informed consent form prior to being enrolled in the present study.

Totally, 50 community-based elderly adults with normal cognitive function and independent live capacity were eligible for screening from October 2012 to May 2013. The eligibility criteria included: (1) age 65 years or older; (2) 5 years or more of education and the Chinese version of Mini-Mental State Examination (CMMSE) score ≥ 24 points; (3) Chinese mandarin as their native language; and (4) having no disability and no difficulty in hearing, vision or communication. Exclusion criteria were: (1) prior diagnoses of neurologic diseases, e.g., dementia, Parkinson's diseases, multiple sclerosis or stroke according to International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10; ICD-10-version, [@B25]); (2) history of mental disorders (e.g., major depressive disorder and schizophrenia) diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV; American-Psychiatric-Association, [@B1]); (3) known diseases contributing to the retina pathologies, e.g., diabetes, glaucoma or increased intraocular pressure (more than 22 mmHg), cataract and macular degeneration; and (4) having contraindications for MRI examination, e.g., metal implants, artificial joints or heart pacemaker.

Screening assessments for each participant were performed by research assistants and confirmed by professional psychiatrists. Demographic characteristics were collected including age, gender, education, height and weight. Moreover, the participants were arranged to have physical examinations and to check the basic laboratory results, such as liver function, renal function, and the levels of blood glucose and blood fats.

Optical Coherence Tomography (OCT) {#s2-2}
----------------------------------

Retinal imaging was conducted on the same day as the cognitive assessment. The technologist performed all of the OCT examinations according to a standard protocol, and a board-certified ophthalmologist and retina specialist reviewed all of the OCT images to ensure the exclusion of participants with poor quality OCT images. Specifically, all the OCT scans were performed in a dark and enclosed room according to a repeat-scan protocol, which has been proved to be a precise method for measuring RNFL thickness in normal eyes (Cheung et al., [@B13]). HD-OCT 4000 (Carl Zeiss Meditec, Inc., Dublin, CA, USA) and intraocular pressure measurements (TX-20 Full Auto Tonometer; Canon 188 USA Inc., Irvine, CA, USA) were performed for all participants as described by Cheung et al. ([@B13]). The polarization and Z-offset, as determined from the OCT settings, were optimized to assure the best possible scanning quality before the scan was obtained. A default Optic Disc Cube 200 × 200 protocol (software version 4.6) was used to determine the peripapillary RNFL thickness.

A scan was saved only if the fundus image was sufficiently visible to distinguish the optic disc and the scanning circle and if there were no obvious movement artifacts with missing data at the acquired scan pattern. Images with eye movements during scans, poor focus, or signal strength less than 4/10 were excluded. RNFL thickness was measured three times per eye and the average of these three measurements was taken for each eye. The RNFL thickness in superior, inferior, nasal and temporal quadrants were also recorded for each participant.

Magnetic Resonance Imaging (MRI) {#s2-3}
--------------------------------

Structural MRI of the whole brain was acquired on a single 3T Gyroscan Intera system (Verio, Siemens, Erlangen, Germany) Scanner at baseline and after the follow-up 12 months. Images were obtained by using a standard 8-channel phased-array head coil. The head was stabilized with small cushions to minimize motion during scanning. A 3D anatomical T1-weighted dataset of the whole head was acquired using a 3D magnetization-prepared rapid acquisition gradient-echo (MPRAGE) sequence: repetition time (TR) = 1,900 ms, echo time (TE) = 3.43 ms, flip angle = 90°, field of view (FOV) = 256 mm, section thickness = 3 mm, matrix = 256 × 256, yielding 160 continuous sagittal slices of 1 mm thickness. MRI processing steps were performed by a research technician (LJ) who was blinded to all clinical information.

Voxel-based morphometry (VBM), within the statistical parametric mapping 8 (SPM8) was used to evaluate brain morphometry on a voxel-wise base. Customized templates and prior probability maps were created in order to reduce any potential normalization bias. Separate customized templates and priors were created for the baseline vs. follow-up comparisons. Therefore, in each comparison, all subjects were registered to the Montreal Neurological Institute (MNI) template using a 12° of freedom affine transformation and segmented into gray matter, white matter and CSF using MNI priors. Gray matter images were normalized to the MNI gray matter prior using a nonlinear discrete cosine transformation. The normalization parameters were applied to the original whole head and the images were segmented using the MNI priors. Average images were created of the whole head, gray matter, white matter and CSF, and smoothed using 8 mm full-width at half-maximum (FWHM) smoothing kernel.

FreeSurfer software package 5.3.0[^1^](#fn0001){ref-type="fn"} for Mac OS was used for automatic sub-cortical segmentation and volume estimates of T1-weighted images (Reuter et al., [@B47]). Several processing steps, such as skull stripping, Talairach transforms, atlas registration and spherical surface maps and parcellations were initialized with common information from the within-subject template, which significantly increased reliability and statistical power (Reuter et al., [@B47]). On the basis of the longitudinal processed images, the volumetric measurements of brain structures were performed by longitudinal pipeline of FreeSurfer software. All two-time points were first processed with the cross-sectional stream. Then, a base template was created from all two-time points, which operated as an initial estimate for the segmentation and surface reconstruction. The two measurement time points were then registered to this template to ensure non-biased analysis with regard to the two-time points. All reconstructed data were visually checked for segmentation accuracy at the baseline and follow-up. The MRI parameters included cortical gray matter volume, cortical white matter volume and white matter hyperintensity (WMH), as well as the volumes of specific brain structures, e.g., hippocampus and cingulate cortex.

Neuropsychological Assessments {#s2-4}
------------------------------

The general cognitive function at the enrollment was screened by using the CMMSE (Li et al., [@B34]) and the daily living function was assessed by using the Chinese version of Activities of Daily Living Scale (ADL; Chen et al., [@B9]), which included a Physical Self-Maintenance Scale (PSMS; six items) and an instrumental ADL (IADL; eight items). The Chinese version of Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was administrated to evaluate five specific cognitive domains for each participant: Immediate Memory, Visuospatial Memory, Language, Attention and Delayed Memory. We specifically focused on the cognitive domains of Immediate Memory (including subtests of list learning and story memory) and Delayed Memory (including subtests of list recall, list recognition, story recall and figure recall) in this study. The reliability and validity of RBANS in Chinese elderly community have been validated, and widely used in the field of neuropsychology (Cheng et al., [@B11]). Moreover, these tests have been used in our previous studies and showed great sensitivity to the cognitive function most vulnerable to aging (Shen et al., [@B52], [@B51]; Shi et al., [@B53]). All the neuropsychological assessments were conducted by two trained researchers in the field of psychiatry (ZS and XC) according to the standard manual.

Statistical Analysis {#s2-5}
--------------------

The *Kolmogorov-Smirnov* test was used to test the normality of all variables. The between-group differences were compared using a Student's *t*-test for continuous variables \[mean ± standard deviation (SD)\] or a *Chi-square* test for categorical variables \[N (%)\]. *Paired t*-test was used to assess the changes of OCT, MRI and cognitive variables between baseline and follow-up measurements. Given that the measurement units for RNFL (μm) and brain structures (mm^3^) were dissimilar, raw data of longitudinal changes of OCT, MRI and cognitive variables were transferred into the change rate per year (%) for further statistical analysis. We initially applied a *Spearman* correlation to initially screen for the potential associations among RNFL thickness, brain structure volumes and cognitive function. And then, we used a multiple linear regression to predict such associations after adjustment of age and total intracranial volume. All analyses were conducted using SPSS version 20.0 (SPSS Inc., Chicago, IL, USA) and Prism 6 software (La Jolla, CA, USA), with *P* \< 0.05 as the significance level.

Results {#s3}
=======

Characteristics of Participants {#s3-1}
-------------------------------

Fifty participants were screened and 10 of them were excluded: three refused to have OCT examination, four had contraindications to receive MRI scanning, and three withdrew from the study after signing the informed consent form. Thus, 40 participants were enrolled for the baseline study. The mean age of participants was 71.8 ± 3.9 years old, with 24 (60%) being male. The average CMMSE score was 27.0 ± 2.6 out of 30 points. After 12 months, 12 (30%) participants dropped from the study: six of them expressed a lack of interest in participating in the study, two of them were unavailable for MRI examination, and four of them lost the follow-up contact information. Finally, 28 participants were included in the data analysis ([Figure 1](#F1){ref-type="fig"}). The demographic and clinical data of the participants were presented in [Table 1](#T1){ref-type="table"}. There were no significant differences in the baseline demographic or clinical features between the participants who stayed in the current studies and those who had dropped out from the studies.

![Flow diagram. The diagram shows that 50 participants were initially screened for the study. There were 40 participants eligible for baseline assessments and 28 participants completed the follow-up assessments after a period of 12 months. Finally, the data obtained from these 28 participants were included for the data analysis.](fnagi-11-00069-g0001){#F1}

###### 

Baseline characteristics of the study population.

  Variables               Total (*N* = 40)       Followed (*N* = 28)    Dropped out (*N* = 12)   *P*-value
  ----------------------- ---------------------- ---------------------- ------------------------ -----------
  Age (years)             71.8 ± 3.9             72.2 ± 4.0             70.9 ± 4.6               0.356
  Gender, male, No. (%)   24 (60%)               14 (50%)               10 (83%)                 0.105
  Education (years)       10.2 ± 4.2             9.8 ± 4.3              11.1 ± 3.7               0.358
  Height (cm)             159.2 ± 8.2            158.5 ± 6.7            160.8 ± 11.1             0.548
  Weight (kg)             57.8 ± 13.5            59.1 ± 10.9            54.8 ± 18.5              0.353
  IOP (mmHg)              16.6 ± 2.3             16.8 ± 2.2             16.3 ± 2.4               0.534
  ADL score (point)       14.2 ± 0.9             14.2 ± 0.7             14.2 ± 0.7               0.339
  CMMSE score (points)    27.0 ± 2.6             27.2 ± 2.3             26.5 ± 3.3               0.432
  ICV (mm^3^)             1549670.4 ± 156034.0   1533584.0 ± 159324.0   1587205.2 ± 147708.2     0.326

*Abbreviation: IOP, intraocular pressure; ADL, Activities of Daily Living Scale; CMMSE, Chinese version of Mini-Mental State Examination; ICV, total intracranial volume. *P* values were calculated from *Studentt*-test or *Chi-square* test to compare the differences of baseline characteristics between the participants who stayed in the studies and the participants who dropped from the studies*.

Longitudinal Changes of RNFL Thickness, Brain Structure Volume and Cognitive Function {#s3-2}
-------------------------------------------------------------------------------------

First, we found that the changes in RNFL thickness within 12 months differed in four quadrants. Specifically, RNFL thickness in the superior quadrant was significantly thinner than that at the baseline examination (107.4 ± 13.9 μm vs. 102.8 ± 15.9 μm, *P* = 0.003), with a decreasing rate of 4.4%. While RNFL thickness in other quadrants did not present significant changes as compared to the baseline measurements. Moreover, the changes of different brain structure volumes showed a consistent decrease trend over the 12 months. The volumes of cortical gray matter (564886.3 ± 41772.6 mm^3^ vs. 561456.7 ± 40820.9 mm^3^, *P* \< 0.001) and white matter (407043.0 ± 39187.4 mm^3^ vs. 402466.0 ± 38485.0 mm^3^, *P* \< 0.001) reduced significantly as compared to the volumes of baseline assessments. The WMH increased by 13.6% (3644.1 ± 3094.8 mm^3^ vs. 4140.5 ± 3529.0 mm^3^, *P* \< 0.001) during the period of 12-month follow-up. Furthermore, the volumes of hippocampus (7596.1 ± 900.5 mm^3^ vs. 7442.6 ± 883.1 mm^3^, *P* \< 0.001) and the total cingulated cortex (2775.2 ± 334.1 mm^3^ vs. 2726.3 ± 332.3 mm^3^, *P* \< 0.001) also demonstrated an obviously decreasing trend within 12 months. The longitudinal changes of other brain structure volumes, e.g., amygdale or caudate, were not statistically significant. As for the decline of specific cognitive domains measured by RBANS, we found the list learning (−12.0%, *P* \< 0.001) and figure recall (−21.9%, *P* = 0.003) decreased significantly as compared to those at the baseline assessments. Moreover, the cognitive domains of Immediate Memory (−6.3%, *P* = 0.004) and Delayed Memory (−6.2%, *P* = 0.007) also reduced significantly from the baseline assessments over the follow-up 12 months ([Table 2](#T2){ref-type="table"}).

###### 

Longitudinal changes of RNFL thickness, brain structure volume and cognitive function over 12 months.

  Variables (*N* = 28)         Baseline             Follow-up            Change rate   *P*-value
  ---------------------------- -------------------- -------------------- ------------- -------------
  **RNFL thickness**                                                                   
  Average RNFL (μm)            87.6 ± 10.2          87.0 ± 8.5           −0.3%         \<0.587
  Superior RNFL (μm)           107.4 ± 13.9         102.8 ± 15.9         −4.4%         **\<0.003**
  Inferior RNFL (μm)           113.6 ± 19.5         111.2 ± 17.3         −1.4%         \<0.155
  Nasal RNFL (μm)              65.0 ± 9.0           65.3 ± 10.5          0.8%          \<0.830
  Temporal RNFL (μm)           65.2 ± 9.8           66.0 ± 9.6           2.2%          \<0.624
  **Brian structure volume**                                                           
  Gray matter (mm^3^)          564886.3 ± 41772.6   561456.7 ± 40820.9   −0.6%         **\<0.001**
  White matter (mm^3^)         407043.0 ± 39187.4   402466.0 ± 38485.0   −1.1%         **\<0.001**
  WMH (mm^3^)                  3644.1 ± 3094.8      4140.5 ± 3529.0      13.6%         **\<0.001**
  Hippocampus (mm^3^)          7596.1 ± 900.5       7442.6 ± 883.1       −2.0%         **\<0.001**
  CC_mid_post (mm^3^)          325.4 ± 66.5         317.4 ± 61.6         −2.5%         **\<0.004**
  CC_anterior (mm^3^)          793.6 ± 142.7        773.0 ± 140.5        −2.6%         **\<0.001**
  CC_central (mm^3^)           373.7 ± 51.6         366.7 ± 50.9         −1.9%         **\<0.047**
  CC_total (mm^3^)             2775.2 ± 334.1       2726.3 ± 332.3       −1.8%         **\<0.001**
  **Cognitive function**                                                               
  List learning                28.8 ± 6.5           25.4 ± 7.6           −12.0%        **\<0.001**
  List recall                  6.8 ± 3.0            5.8 ± 3.3            −15.3%        \<0.087
  List recognition             19.8 ± 0.5           19.5 ± 0.7           −1.2%         \<0.070
  Story memory                 16.9 ± 3.6           16.3 ± 4.2           −3.8%         \<0.236
  Story recall                 9.3 ± 2.0            8.5 ± 2.8            −8.5%         \<0.102
  Figure recall                16.1 ± 3.4           12.1 ± 5.8           −21.9%        **\<0.003**
  Immediate Memory             104.3 ± 16.5         97.8 ± 21.3          −6.3%         **\<0.004**
  Delayed Memory               113.5 ± 13.1         106.5 ± 14.1         −6.2%         **\<0.007**

*Abbreviations: RNFL, retinal nerve fiber layer; WMH, white matter hyperintensities; CC, Cingulate cortex volume; CC_mid_post, middle posterior cingulate cortex volume; CC_anterior, anterior cingulated cortex volume; CC_central, central cingulated cortex volume; CC_total, total cingulated cortex volume. Change rates were defined by the ratio of the change value with the baseline value. *P* values were calculated from *Pairedt*-test to compare the RNFL thickness, brain structure volume and cognitive function between the baseline and the time of follow-up. Significant *P* values are indicated in bold*.

Giving that the aging process may differ in male and female subjects, we performed further analysis to compare RNFL reduction, brain atrophy and decline of cognitive function of different sex group over 12 months. The reduction of RNFL thickness in the inferior quadrant tended to be more significant in male participants in relative to female participants (*P* = 0.057). Besides, male participants showed more decline in Delayed Memory as compared to female participants (*P* = 0.019; [Supplementary Table S1](#SM1){ref-type="supplementary-material"}).

Association Between RNFL Thinning and Brain Atrophy {#s3-3}
---------------------------------------------------

The associations between the RNFL thinning and brain atrophy during the 12 months follow-up were analyzed. Results suggested that the average RNFL thinning was associated with the reduction of hippocampus volume (*R* = 0.38, *P* = 0.048), but the association disappeared after age and total intracranial volume being adjusted (*β* = 0.33, *P* = 0.104). Interestingly, we found that the reduction of RNFL thickness was selectively associated with a volumetric decrease of the cingulate cortex. The reduction of RNFL thickness in the superior quadrant was associated with the volumetric decline of middle posterior cingulate cortex (*R* = 0.41, *P* = 0.028) and total cingulate cortex (*R* = 0.40, *P* = 0.035), but the significance disappeared after the adjustment of age and total intracranial volume. While the average RNFL thinning was inversely associated with the decrease of central cingulate cortex volume after the adjustment of age and total intracranial volume (*β* = −0.41, *P* = 0.039). Specifically, the reduction of RNFL thickness in the inferior, not other quadrants, was independently associated with the decline of central cingulate cortex volume after the adjustment (*β* = −0.52, *P* = 0.006; [Table 3](#T3){ref-type="table"}). These data suggested that the reduction of RNFL thickness might reflect the atrophy process of cingulate cortex over 12 months in nondemented population.

###### 

Associations between RNFL thinning and brain atrophy.

  Reduction of RNFL   Decrease of brain structure volume                                                                                                      
  ------------------- ------------------------------------ --------------- --------------- -------------- --------------- --------------- ------------------- ---------------
  Average RNFL        0.38 (0.053)                         −0.17 (0.397)   −0.01 (0.989)   0.33 (0.104)   0.04 (0.851)    0.24 (0.243)    **−0.41 (0.039)**   0.09 (0.632)
  Superior RNFL       −0.01 (0.959)                        0.13 (0.513)    0.06 (0.760)    0.26 (0.197)   0.37 (0.052)    0.10 (0.642)    0.06 (0.764)        0.31 (0.111)
  Inferior RNFL       0.05 (0.792)                         −0.07 (0.735)   −0.07 (0.722)   0.03 (0.872)   −0.01 (0.961)   −0.07 (0.724)   **−0.52 (0.006)**   0.01 (0.978)
  Nasal RNFL          0.03 (0.901)                         −0.21 (0.305)   0.13 (0.535)    0.27 (0.185)   −0.22 (0.274)   −0.21 (0.297)   −0.33 (0.092)       −0.16 (0.428)
  Temporal RNFL       0.27 (0.183)                         −0.20 (0.323)   −0.02 (0.921)   0.18 (0.389)   −0.12 (0.532)   0.09 (0.671)    −0.17 (0.394)       0.15 (0.456)

*Abbreviations: RNFL, retinal nerve fiber layer; WMH, white matter hyperintensities; CC, Cingulate cortex; CC_mid_post, middle posterior cingulate cortex volume; CC_anterior, anterior cingulated cortex volume; CC_central, central cingulated cortex volume; CC_total, total cingulated cortex volume. The data were represented as standardized regression coefficient (*P* values), which were generated with multivariate linear regression after the adjustment of age and total intracranial volume. Significant results are indicated in bold*.

Association of RNFL Thinning and Brain Atrophy With Cognitive Decline {#s3-4}
---------------------------------------------------------------------

We determined the association between the changes of RNFL thickness and cognitive function during the follow-up period. We found that less reduction of average RNFL thickness was associated with a worse decrease in the test score of list recall (*β* = −0.48, *P* = 0.019) and the index score of Delayed Memory (*β* = −0.44, *P* = 0.017) after adjusting for age, gender and education years. Specifically, the reduction of RNFL thickness in the inferior quadrant (*β* = −0.49, *P* = 0.011) and temporal quadrant (*β* = −0.45, *P* = 0.039) were inversely associated with the decline of Delayed Memory after age, gender and education years being adjusted ([Supplementary Table S2](#SM1){ref-type="supplementary-material"}).

The association between the longitudinal changes of brain structure volume and cognitive function were analyzed at the same time. We found that the atrophy of anterior cingulate cortex (*β* = 0.45, *P* = 0.024) and mid-posterior cingulate cortex (*β* = 0.64, *P* = 0.001) were respectively associated with the decline in the test score of list recognition after adjusting for age, gender and education years. Moreover, the atrophy of mid-posterior cingulate cortex was associated with the decline in Delayed Memory (*β* = 0.45, *P* = 0.012) after the adjustment. In addition, we found that the aggregation of white matter hyperintensities was inversely associated with the decline in the test score of list recall (*β* = −0.42, *P* = 0.040) and list recognition (*β* = −0.48, *P* = 0.015) after adjusting for age, gender and education years ([Supplementary Table S2](#SM1){ref-type="supplementary-material"}).

In addition, we further analyzed the association of cognitive decline with RNFL thinning in *left* and *right* eye, brain atrophy in*left* and *right* hemisphere, respectively. We found that the reduction of average RNFL thickness in the *left* eye was inversely associated with Delayed Memory (*β* = −0.40, *P* = 0.043). The reduction of nasal RNFL thickness in the *right* eye was inversely associated with list learning (*β* = −0.44, *P* = 0.026) and list recognition (*β* = −0.41, *P* = 0.036). Moreover, the reduction of *right* hippocampus volume was inversely associated with the decline of test score of list learning (*β* = −0.52, *P* = 0.010) and decline of Immediate Memory (*β* = −0.53, *P* = 0.008; [Supplementary Tables S3, S4](#SM1){ref-type="supplementary-material"}).

Collectively, these findings suggested that RNFL thickness reduction was associated with cingulate cortex atrophy and cognitive deterioration, especially the decline of episodic memory over 12 months.

Discussion {#s4}
==========

In this prospective study, we investigated the association between the longitudinal changes of RNFL thickness and brain structure volume in older adults with normal cognitive function within 12 months. We found that RNFL thinning was associated with the specific brain atrophy (e.g., central cingulate cortex) and the decline of episodic memory. The current results demonstrated the potential retinal-brain associations, which further validate RNFL thickness determined by OCT might be an inexpensive, noninvasive and easily reproducible biomarker for early detection and longitudinal monitoring of neurocognitive aging or AD.

A depletion of optic nerve ganglion cells and their axons might be part of the neurodegeneration and retinal measures were suggested to reflect global central nervous system pathology of neurodegeneration (London et al., [@B38]). Ocular manifestations in AD have been studied extensively over the few decades (Blanks et al., [@B5]; Kromer et al., [@B33]; Loh et al., [@B37]). As coalesce of axons of ganglion cells, RNFL thickness is originally supposed to provide a snapshot of the anterior visual pathway. But later studies found that ocular degeneration in AD was most severe at the posterior parts of the optic nerve (close to the optic chiasm), suggesting the initial site of ocular pathology was intracranial (Sadun and Bassi, [@B49]). Thus, RNFL thickness determined by OCT may represent the neurodegeneration of the brain. However, longitudinal change of RNFL thickness and the association of RNFL reduction and brain atrophy remain unclear.

In this study, RNFL thickness in the superior and inferior quadrants receded more significantly than the RNFL thickness in the other quadrants over the period of follow-up. Specifically, RNFL thickness in the inferior quadrant could be more affected in male participants. Previous studies have consistently reported the quadrant variations of RNFL attenuation in the aged population. Most studies suggested that the superior and inferior quadrants were more noticeably affected during the disease progression (Kirbas et al., [@B29]; Liu et al., [@B36]); while some other studies showed a significant decrease of RNFL thickness in the temporal quadrant (Zhu et al., [@B64]; Wu et al., [@B62]). The exact reason why there is a regional variation of RNFL thickness reduction is not known at the present time. It could be due to the fact that the size of axons of RNFL degenerated differently in different quadrants of RNFL (Gelfand et al., [@B18]). Specifically, Gelfand et al. ([@B18]) noted that affected areas of the retina contained axons derived from small parvocellular neurons that have small diameter axons. As is known, thinner axons are more vulnerable to insult that involves oxidative stress and aggregation of amyloid proteins during aging process (London et al., [@B38]). Future large-scale studies are warranted to observe the longitudinally changing of RNFL thickness in each quadrant across normal aging and patients with MCI or AD.

As for the longitudinal changes of brain structure volumes, we found a significant decrease of cortical gray and white matter volumes, hippocampus volume and cingulate cortex volume, and an apparent aggravation of white matter hyperintensities. However, there was no significant difference in brain atrophy between male and female individuals. These findings might also be due to the short period follow-up and small sample size. In the present study, it was originally expected that reduction of RNFL thickness would associate with hippocampus atrophy, the gold-standard biomarker of AD (Jack et al., [@B26]). Moreover, as a coalesce of axons of ganglion cells, RNFL thinning was expected to be associated with intracranial white matter atrophy or WMH aggravation. Unexpectedly, the reduction of average RNFL thickness was not associated with hippocampus atrophy, intracranial white matter atrophy or matter hyperintensity aggravation. Instead, we found that RNFL thinning was inversely associated with the decrease in cingulate cortex volume, which indicated that the less thinning rate of RNFL might mirror the greater intracranial atrophy of aging-sensitive brain structures, e.g., cingulate cortex.

These results confirmed the biological association between RNFL and intracranial structures and supported that the attenuation of RNFL could be an applaudable peripheral marker for observing intracranial neurodegeneration. However, the mechanisms underlying the inverse association remained unclear. Since previous evidences have suggested that the atrophy was not uniform across different brain regions, nor did it follow a linear trajectory (McDonald et al., [@B40]), and the reduction rate of RNFL thickness might not be linear patterns or paralleled with the atrophy rate of cingulate cortex volume, further studies with more time points will be necessary to investigate nonlinear effects of the neurodegenerative process (Sabuncu et al., [@B48]).

Although we have adjusted gender as a confounder when investigating the association between cognitive decline and RNFL or brain structures, we want to assess whether there is a difference in male and female participants. In the present study, female participants showed less decline in Delayed Memory within 12 months as compared to male participants. These results are supported by previous studies which emphasize the importance of sex differences in related to pathogenesis and prevention of AD \[reviewed in Li and Singh ([@B35]); Nebel et al. ([@B43])\]. Consistently, Gerstorf et al. ([@B19]) have reported that healthy elderly women usually always outperformed age-matched men on episodic memory tasks.

Moreover, we found that the reduction of RNFL thickness was inversely associated with the decline of episodic memory (e.g., list recall and delayed memory) after adjusted age, gender and education, namely, the less but not greater annual reduction rate of RNFL thickness indicated severe cognitive decline. These findings were consistent with our previous studies (Shen et al., [@B52]; Shi et al., [@B53]), which might be due to the gliotic reactive changes in the pathogenesis of inner retina. Specifically, gliosis, hypertrophy and proliferation of astrocytes and astrocytic neuroinflammation may occur before the onset of neuronal death and therefore may obfuscate the detection of thinner RNFL (Knoll et al., [@B31]).

Meanwhile, white matter hyperintensities aggravation and the cingulate cortex atrophy were also associated with the decline of episodic memory after the adjustment of age, gender and education. Accordingly, a higher global white matter hyperintensities burden appeared to increase the risk of cognitive decline in elderly adults (Nolze-Charron et al., [@B44]). These results lend support to the previous findings that patients with white matter hyperintensities are at an increased risk of clinical progression and cognitive decline, and are vulnerable to suffer the deficits of episodic memory (Fujishima et al., [@B17]; Benedictus et al., [@B4]). The possible explanation was that white matter hyperintensities disrupt the cholinergic pathway and contribute to the deterioration of cognitive function (Bocti et al., [@B6]). In addition, we also demonstrated that cingulate cortex could be more vulnerable to the age-related neurodegeneration than the other brain regions in cognitively normal older adults, which was consistent with previous findings (Mann et al., [@B39]). Cingulate cortex is the central hub in cognitive brain networks (Jockwitz et al., [@B28]). Particularly, posterior cingulate cortex has important relevance to process episodic memory tasks (Brugnolo et al., [@B7]). Atrophy of posterior cingulate cortex could characterize old individuals at risk of developing AD (Chételat et al., [@B12]; Conway et al., [@B14]; Teipel and Grothe, [@B57]). The findings from current studies further suggest that cingulate cortex plays a key role in neurodegeneration during the process of aging. Additionally, we found that hippocampus atrophy in the *right*, not the *left*, hemisphere was inversely associated with the cognitive decline of Immediate Memory (determined by worst list learning test). We speculated that the discrepancy between*left* and *right* hemisphere might be attributed to the compensatory mechanism of non-dominant hemisphere, as suggested in previous studies (Huijbers et al., [@B24]).

There were several limitations to the current study. First, the sample size at the follow-up assessment was small (*N* = 28), and the drop-off rate was relatively high (30%). However, we compared the demographic characteristics of the participants who stayed for the study and the participants who dropped from the study, and we did not find any significant differences between the two populations ([Table 1](#T1){ref-type="table"}). Second, we did not adjust for multiple comparisons when calculating the retinal-brain associations, thus the identified association and the statistical power should be confirmed in a larger scale cohort. Finally, the current study only included cognitively normal older adults and the follow-up period of 12 months was relatively short to observe the cognitive conversion in the participants with normal cognitive function. It remains unclear whether these findings could be repeated in both MCI and AD dementia patients. But serving as a pilot investigation, we established a system to further validate the potential value of RNFL thickness reduction as a biomarker of AD.

In conclusion, longitudinal reduction of RNFL thickness measured by OCT could reflect the intracranial neurodegenerative process and cognitive impairment in aging participants. OCT measurement, a noninvasive, reproducible, rapid and well-tolerated examination for retinal characteristics, would be a useful complementary technique to MRI in evaluating longitudinal changes of neurodegeneration. It provides the advantages of detecting participants at the prodromal stage of AD and targeting population for cognitive intervention.

Data Availability {#s5}
=================

All datasets generated for this study are included in the manuscript and/or the [Supplementary Files](#SM1){ref-type="supplementary-material"}.

Author Contributions {#s6}
====================

YS and CL: study concept and design, administrative, technical, material support and study supervision. ZS, HZ, JH, LJ, XC, YC, XM, CL and YS: study conduct, acquisition, analysis and interpretation of data. ZS and YS: drafting of the manuscript. ZS, CL and YS: critically revising article for important intellectual content. ZS, HZ, JH, LJ, XC, YC, XM, CL and YS: final approval of the version to be published, agreement to be accountable for the work in ensuring that related questions are appropriately investigated and resolved.

Conflict of Interest Statement {#s7}
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was supported by National Natural Science Foundation of China (81720108012, 81571034) and Natural Science Foundation of Shanghai (16410724500) to YS; National Natural Science Foundation of China (81371505) to CL.

^1^<http://surfer.nmr.mgh.harvard.edu>

Supplementary Material {#s8}
======================

The Supplementary Material for this article can be found online at: <https://www.frontiersin.org/articles/10.3389/fnagi.2019.00069/full#supplementary-material>.

###### 

Click here for additional data file.

[^1]: Edited by: Xiongwei Zhu, Case Western Reserve University, United States

[^2]: Reviewed by: Rena Li, The Roskamp Institute, United States; Daqing Ma, Imperial College London, United Kingdom
